Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (978)	6/7/2000 8:36:00 AM
From: Toni Wheeler	Read Replies (1) \| Respond to of 1018

Will it be the acquiror OR the acquiree?? Interesting.... I-Flow Corporation Engages Investment Banking Firm <<<LAKE FOREST, Calif.--(BUSINESS WIRE)--June 7, 2000--I-Flow Corporation (Nasdaq:IFLO) today announced that it has engaged the investment banking firm of Dominick & Dominick LLC, New York City, to assist management in the identification and evaluation of potential acquisitions and strategic partnerships. Chairman, President and Chief Executive Officer Donald M. Earhart said: "In 1996 I-Flow began an aggressive program to expand the Company's technology base and enter new markets where the opportunity for growth is substantial. Synergistic acquisitions, global corporate partnerships and innovative proprietary products like the ON-Q(TM), PainBuster(TM) and Soaker Catheter(TM) pain management infusion systems, plus the contribution of our InfuSystem subsidiary, are the underpinnings of the dramatic growth we have achieved with this plan. "The 1996 acquisition of Block Medical, Inc., a manufacturer and marketer of ambulatory infusion devices, was the first step in leveraging I-Flow's technology into the home care market. With the acquisition of InfuSystem, Inc., a national ambulatory infusion pump management and distribution company serving the cancer infusion therapy market, I-Flow leveraged its technology into outpatient oncology treatment. "Our relationships with world class pharmaceutical manufacturers enabled I-Flow to become competitive in wound site post-operative pain management. And, the acquisition of Spinal Specialties, Inc., which designs and manufactures custom spinal, epidural and nerve block infusion kits, provides I-Flow with a strong foundation for building our strategy in chronic and acute pain management. "We now have the critical mass to support a much larger company and serve additional markets that complement our infusion technology. We look forward to working with Dominick & Dominick to take full advantage of future growth opportunities." About I-Flow I-Flow Corporation (www.i-flowcorp.com) designs, develops and markets technically advanced, low-cost ambulatory infusion systems that are redefining the standard of care by providing life-enhancing, cost-effective solutions for pain management and infusion therapy. The statements contained in this release that are not historical facts may be deemed to contain forward-looking statements with respect to events, the occurrence of which involve significant risks and uncertainties, including, without limitation, future demand for the Company's services, competition within the industry, and other risks or uncertainties detailed in the Company's Securities and Exchange Commission filings. CONTACT: I-Flow Corp. Gayle L. Arnold, 949/206-2700 www.i-flowcorp.com or Neil Berkman Associates John Hicks, 310/277-5162 info@BerkmanAssociates.com KEYWORD: CALIFORNIA BW0072 JUN 07,2000 5:00 PACIFIC 8:00 EASTERN>>>